Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1977 1
1978 4
1982 1
1983 1
1985 3
1986 2
1987 3
1988 2
1989 5
1990 4
1991 1
1992 1
1993 2
1994 3
1995 2
1997 4
1998 3
1999 5
2000 2
2001 4
2002 3
2003 4
2004 2
2005 10
2006 4
2007 2
2008 8
2009 10
2010 2
2011 6
2012 1
2013 5
2014 10
2015 12
2016 8
2017 9
2018 7
2019 7
2020 13
2021 16
2022 19
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
Baloni P, Arnold M, Buitrago L, Nho K, Moreno H, Huynh K, Brauner B, Louie G, Kueider-Paisley A, Suhre K, Saykin AJ, Ekroos K, Meikle PJ, Hood L, Price ND; Alzheimer’s Disease Metabolomics Consortium; Doraiswamy PM, Funk CC, Hernández AI, Kastenmüller G, Baillie R, Han X, Kaddurah-Daouk R. Baloni P, et al. Commun Biol. 2022 Oct 8;5(1):1074. doi: 10.1038/s42003-022-04011-6. Commun Biol. 2022. PMID: 36209301 Free PMC article.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. Diabetes Care. 2022. PMID: 35061867 Free PMC article. Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA, Moreno-Sanchez PM, Pires-Afonso Y, Kaoma T, Nosirov B, Scafidi A, Ermini L, Lipsa A, Oudin A, Kyriakis D, Grzyb K, Poovathingal SK, Poli A, Muller A, Toth R, Klink B, Berchem G, Berthold C, Hertel F, Mittelbronn M, Heiland DH, Skupin A, Nazarov PV, Niclou SP, Michelucci A, Golebiewska A. Yabo YA, et al. bioRxiv [Preprint]. 2023 Dec 12:2023.03.05.531162. doi: 10.1101/2023.03.05.531162. bioRxiv. 2023. PMID: 36945572 Free PMC article. Updated. Preprint.
Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves' orbitopathy: an observational study.
Boutzios G, Chatzi S, Goules AV, Mina A, Charonis GC, Vlachoyiannopoulos PG, Tzioufas AG. Boutzios G, et al. Front Endocrinol (Lausanne). 2023 Jun 22;14:1186105. doi: 10.3389/fendo.2023.1186105. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37424868 Free PMC article.
Treatment with TCZ reduced significantly median CAS by 3 units (p=0.002), TSI levels by 11.02 IU/L (p=0.006), Hertel score on the right eye by 2.3 mm (p=0.003), Hertel score on the left eye by 1.6 mm (p=0.002), while diplopia persisted in fewer patients (25%) …
Treatment with TCZ reduced significantly median CAS by 3 units (p=0.002), TSI levels by 11.02 IU/L (p=0.006), Hertel score on …
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
Biswas A, Salvucci M, Connor K, Düssmann H, Carberry S, Fichtner M, King E, Murphy B, O'Farrell AC, Cryan J, Beausang A, Heffernan J, Cremona M, Hennessy BT, Clerkin J, Sweeney KJ, MacNally S, Brett F, O'Halloran P, Bacon O, Furney S, Verreault M, Quissac E, Bielle F, Ahmed MH, Idbaih A, Leenstra S, Ntafoulis I, Fabro F, Lamfers M, Golebiewska A, Hertel F, Niclou SP, Yen RTC, Kremer A, Dilcan G, Lodi F, Arijs I, Lambrechts D, Purushothama MK, Kel A, Byrne AT, Prehn JHM. Biswas A, et al. J Neurooncol. 2023 Jun;163(2):327-338. doi: 10.1007/s11060-023-04341-3. Epub 2023 May 26. J Neurooncol. 2023. PMID: 37237151 Free PMC article.
Behavioral responses of terrestrial mammals to COVID-19 lockdowns.
Tucker MA, Schipper AM, Adams TSF, Attias N, Avgar T, Babic NL, Barker KJ, Bastille-Rousseau G, Behr DM, Belant JL, Beyer DE Jr, Blaum N, Blount JD, Bockmühl D, Pires Boulhosa RL, Brown MB, Buuveibaatar B, Cagnacci F, Calabrese JM, Černe R, Chamaillé-Jammes S, Chan AN, Chase MJ, Chaval Y, Chenaux-Ibrahim Y, Cherry SG, Ćirović D, Çoban E, Cole EK, Conlee L, Courtemanch A, Cozzi G, Davidson SC, DeBloois D, Dejid N, DeNicola V, Desbiez ALJ, Douglas-Hamilton I, Drake D, Egan M, Eikelboom JAJ, Fagan WF, Farmer MJ, Fennessy J, Finnegan SP, Fleming CH, Fournier B, Fowler NL, Gantchoff MG, Garnier A, Gehr B, Geremia C, Goheen JR, Hauptfleisch ML, Hebblewhite M, Heim M, Hertel AG, Heurich M, Hewison AJM, Hodson J, Hoffman N, Hopcraft JGC, Huber D, Isaac EJ, Janik K, Ježek M, Johansson Ö, Jordan NR, Kaczensky P, Kamaru DN, Kauffman MJ, Kautz TM, Kays R, Kelly AP, Kindberg J, Krofel M, Kusak J, Lamb CT, LaSharr TN, Leimgruber P, Leitner H, Lierz M, Linnell JDC, Lkhagvaja P, Long RA, López-Bao JV, Loretto MC, Marchand P, Martin H, Martinez LA, McBride RT Jr, McLaren AAD, Meisingset E, Melzheimer J, Merrill EH, Middleton AD, Monteith KL, Moore SA, Van Moorter B, Morellet N, Morrison T, Müller … See abstract for full author list ➔ Tucker MA, et al. Science. 2023 Jun 9;380(6649):1059-1064. doi: 10.1126/science.abo6499. Epub 2023 Jun 8. Science. 2023. PMID: 37289888
209 results